Overview
AugMed is our open-source platform for running clinical case-review experiments with practicing clinicians. Within the NIH AIM-AHEAD consortium, we used AugMed to study a colorectal cancer risk-assessment task, examining how AI recommendations affect clinicians’ judgments, screening recommendations, confidence, and attention to patient information.
AIM-AHEAD support for this study ended in September 2025. Analysis and manuscript preparation continue.
What we are studying
- How clinicians’ risk-assessment judgments change when an AI recommendation is present versus absent
- Whether AI presence shifts which patient information clinicians attend to
- How confidence and screening recommendations respond to AI input
Status
This project is in the analysis stage. We are not reporting effect sizes, sample sizes, or publication status here; those will be added once a paper is out.